pubmed-article:12411297 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12411297 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:12411297 | lifeskim:mentions | umls-concept:C0330390 | lld:lifeskim |
pubmed-article:12411297 | lifeskim:mentions | umls-concept:C0017337 | lld:lifeskim |
pubmed-article:12411297 | lifeskim:mentions | umls-concept:C0271979 | lld:lifeskim |
pubmed-article:12411297 | lifeskim:mentions | umls-concept:C1705822 | lld:lifeskim |
pubmed-article:12411297 | lifeskim:mentions | umls-concept:C1947976 | lld:lifeskim |
pubmed-article:12411297 | lifeskim:mentions | umls-concept:C2350240 | lld:lifeskim |
pubmed-article:12411297 | lifeskim:mentions | umls-concept:C0086022 | lld:lifeskim |
pubmed-article:12411297 | lifeskim:mentions | umls-concept:C0017033 | lld:lifeskim |
pubmed-article:12411297 | lifeskim:mentions | umls-concept:C0348011 | lld:lifeskim |
pubmed-article:12411297 | lifeskim:mentions | umls-concept:C0542560 | lld:lifeskim |
pubmed-article:12411297 | lifeskim:mentions | umls-concept:C1705099 | lld:lifeskim |
pubmed-article:12411297 | lifeskim:mentions | umls-concept:C0442335 | lld:lifeskim |
pubmed-article:12411297 | lifeskim:mentions | umls-concept:C1707513 | lld:lifeskim |
pubmed-article:12411297 | lifeskim:mentions | umls-concept:C0591833 | lld:lifeskim |
pubmed-article:12411297 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:12411297 | pubmed:dateCreated | 2003-2-28 | lld:pubmed |
pubmed-article:12411297 | pubmed:abstractText | Increased fetal hemoglobin (HbF) levels diminish the clinical severity of beta-thalassemia and sickle cell anemia. A treatment strategy using autologous stem cell-targeted gene transfer of a gamma-globin gene may therefore have therapeutic potential. We evaluated oncoretroviral- and lentiviral-based gamma-globin vectors for expression in transduced erythroid cell lines. Compared with gamma-globin, oncoretroviral vectors containing either a beta-spectrin or beta-globin promoter and the alpha-globin HS40 element, a gamma-globin lentiviral vector utilizing the beta-globin promoter and elements from the beta-globin locus control region demonstrated a higher probability of expression. This lentiviral vector design was evaluated in lethally irradiated mice that received transplants of transduced bone marrow cells. Long-term, stable erythroid expression of human gamma-globin was observed with levels of vector-encoded gamma-globin mRNA ranging from 9% to 19% of total murine alpha-globin mRNA. The therapeutic efficacy of the vector was subsequently evaluated in a murine model of beta-thalassemia intermedia. The majority of mice that underwent transplantation expressed significant levels of chimeric m(alpha)(2)h(gamma)(2) molecules (termed HbF), the amount of which correlated with the degree of phenotypic improvement. A group of animals with a mean HbF level of 21% displayed a 2.5 g/dL (25 g/L) improvement in Hb concentration and normalization of erythrocyte morphology relative to control animals. gamma-Globin expression and phenotypic improvement was variably lower in other animals due to differences in vector copy number and chromosomal position effects. These data establish the potential of using a gamma-globin lentiviral vector for gene therapy of beta-thalassemia. | lld:pubmed |
pubmed-article:12411297 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12411297 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12411297 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12411297 | pubmed:language | eng | lld:pubmed |
pubmed-article:12411297 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12411297 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:12411297 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12411297 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12411297 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12411297 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12411297 | pubmed:month | Mar | lld:pubmed |
pubmed-article:12411297 | pubmed:issn | 0006-4971 | lld:pubmed |
pubmed-article:12411297 | pubmed:author | pubmed-author:HanawaHidekiH | lld:pubmed |
pubmed-article:12411297 | pubmed:author | pubmed-author:PersonsDerek... | lld:pubmed |
pubmed-article:12411297 | pubmed:author | pubmed-author:NienhuisArthu... | lld:pubmed |
pubmed-article:12411297 | pubmed:author | pubmed-author:HargrovePhill... | lld:pubmed |
pubmed-article:12411297 | pubmed:author | pubmed-author:AllayEsther... | lld:pubmed |
pubmed-article:12411297 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12411297 | pubmed:day | 15 | lld:pubmed |
pubmed-article:12411297 | pubmed:volume | 101 | lld:pubmed |
pubmed-article:12411297 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12411297 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12411297 | pubmed:pagination | 2175-83 | lld:pubmed |
pubmed-article:12411297 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:12411297 | pubmed:meshHeading | pubmed-meshheading:12411297... | lld:pubmed |
pubmed-article:12411297 | pubmed:meshHeading | pubmed-meshheading:12411297... | lld:pubmed |
pubmed-article:12411297 | pubmed:meshHeading | pubmed-meshheading:12411297... | lld:pubmed |
pubmed-article:12411297 | pubmed:meshHeading | pubmed-meshheading:12411297... | lld:pubmed |
pubmed-article:12411297 | pubmed:meshHeading | pubmed-meshheading:12411297... | lld:pubmed |
pubmed-article:12411297 | pubmed:meshHeading | pubmed-meshheading:12411297... | lld:pubmed |
pubmed-article:12411297 | pubmed:meshHeading | pubmed-meshheading:12411297... | lld:pubmed |
pubmed-article:12411297 | pubmed:meshHeading | pubmed-meshheading:12411297... | lld:pubmed |
pubmed-article:12411297 | pubmed:meshHeading | pubmed-meshheading:12411297... | lld:pubmed |
pubmed-article:12411297 | pubmed:meshHeading | pubmed-meshheading:12411297... | lld:pubmed |
pubmed-article:12411297 | pubmed:meshHeading | pubmed-meshheading:12411297... | lld:pubmed |
pubmed-article:12411297 | pubmed:meshHeading | pubmed-meshheading:12411297... | lld:pubmed |
pubmed-article:12411297 | pubmed:meshHeading | pubmed-meshheading:12411297... | lld:pubmed |
pubmed-article:12411297 | pubmed:meshHeading | pubmed-meshheading:12411297... | lld:pubmed |
pubmed-article:12411297 | pubmed:meshHeading | pubmed-meshheading:12411297... | lld:pubmed |
pubmed-article:12411297 | pubmed:meshHeading | pubmed-meshheading:12411297... | lld:pubmed |
pubmed-article:12411297 | pubmed:meshHeading | pubmed-meshheading:12411297... | lld:pubmed |
pubmed-article:12411297 | pubmed:meshHeading | pubmed-meshheading:12411297... | lld:pubmed |
pubmed-article:12411297 | pubmed:meshHeading | pubmed-meshheading:12411297... | lld:pubmed |
pubmed-article:12411297 | pubmed:meshHeading | pubmed-meshheading:12411297... | lld:pubmed |
pubmed-article:12411297 | pubmed:meshHeading | pubmed-meshheading:12411297... | lld:pubmed |
pubmed-article:12411297 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:12411297 | pubmed:articleTitle | The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number. | lld:pubmed |
pubmed-article:12411297 | pubmed:affiliation | Division of Experimental Hematology, Department of Hematology and Oncology, St Jude Children's Research Hospital, Memphis, TN 38105, USA. derek.persons@stjude.org | lld:pubmed |
pubmed-article:12411297 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12411297 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:12411297 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12411297 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12411297 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12411297 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12411297 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12411297 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12411297 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12411297 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12411297 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12411297 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12411297 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12411297 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12411297 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12411297 | lld:pubmed |